ActivistsInvestorsTrumpPoliticiansSerenityCitriniSemianalysisTradeArbitrageSearch

$ARGX:NASDAQ · ARGENX SE

Sector: health

Conviction from: NASDAQ

argenx is a biotechnology company that develops antibody-based therapies for severe autoimmune diseases, including its FcRn-blocker Vyvgart.

2 tracked filer(s) hold this · 1 opened, 0 added, 0 trimmed in 31-MAR-2026

Aggregate 13FScore 48 — mean of 2 scored holder(s) · buyers (new/add) avg 55. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Bridgewater55New buy1,214$886,5240.0%
Ancora42Holds (flat)8$5,8420.0%

Beyond 13F — activists, insiders, politicians & research

Congressional trades all politician trades →

1 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-03-30Alan Armstrong senateBUY$1,001 - $15,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.